Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Absci Corporation - Common Stock (NQ:ABSI)

5.205 -0.335 (-6.05%)
Streaming Delayed Price Updated: 10:28 AM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Absci Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results. 
Via Benzinga
News headline image
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket ↗
INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter. 
Via Benzinga
News headline image
Absci's Return On Capital Employed Insights ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We're starting off Tuesday with a breakdown of all the biggest pre-market stock movers traders need to know about this morning! 
Via InvestorPlace
News headline image
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
From Almirall S.A.
Via Business Wire
News headline image
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
The collaboration expands Absci’s de novo AI drug creation portfolio into dermatology and accelerates discovery for broader chronic inflammatory diseases 
From Absci Corporation
Via GlobeNewswire
News headline image
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
News headline image
Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen
From Absci Corporation
Via GlobeNewswire
News headline image
Absci to Host R&D Day on October 4, 2023
From Absci Corporation
Via GlobeNewswire
News headline image
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
News headline image
The 3 Most Undervalued Penny Stocks to Buy Now: August 2023 ↗
These undervalued penny stocks each provide big upside potential, while trading with relatively high margins of safety. 
Via InvestorPlace
News headline image
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
News headline image
Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer
Addition of veteran biotech leader to further support Absci’s next stage of growth 
From Absci Corporation
Via GlobeNewswire
News headline image
Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development
From Absci Corporation
Via GlobeNewswire
News headline image
Absci to Participate in the UBS MedTech, Tools and Genomics Summit 2023
From Absci Corporation
Via GlobeNewswire
News headline image
Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference
From Absci Corporation
Via GlobeNewswire
News headline image
Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit
From Absci Corporation
Via GlobeNewswire
News headline image
Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips
From Absci Corporation
Via GlobeNewswire
News headline image
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share. 
Via Benzinga
News headline image
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
News headline image
University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies
Absci will apply its generative AI platform to The Kennedy Institute’s immunology biorepository to speed the discovery and development of multiple therapies 
From Absci Corporation
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023 ↗
 
Via Benzinga
News headline image
Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference
From Absci Corporation
Via GlobeNewswire
News headline image
Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology
Absci’s generative AI platform will use M2GEN’s industry-leading clinicogenomic database with the aim of creating better cancer treatments faster 
From Absci Corporation
Via GlobeNewswire
News headline image
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
News headline image
Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation
From Absci Corporation
Via GlobeNewswire
News headline image
Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
From Absci Corporation
Via GlobeNewswire
News headline image
Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership in Switzerland
The generative AI drug company ramps up its internal pipeline and R&D portfolio, tapping into European markets, talent, and tech 
From Absci Corporation
Via GlobeNewswire
News headline image
Absci to Participate in the 43rd Annual Cowen Health Care Conference
From Absci Corporation
Via GlobeNewswire
News headline image
St. John’s Cancer Institute Partners with Absci to Expedite Development of Cancer Therapies
From Absci Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.